Conference & Meetings World Supplements Canada Supplement - Page 17

Saskatoon vaccine and seeking regulatory approval for use in Canada and the US. This virus has killed eight million piglets in North America and cost swine producers more than CAD$400m in lost income. The University’s researchers are also building on pioneering nuclear imaging work with today’s disruptive technology - a new method for producing medical isotopes without using a nuclear reactor or creating radioactive waste. Canadian Isotopes Innovation, a branch of the U of S-owned Canadian Light Source, produces Technetium-99m (Tc-99m), a specific type of isotope used for medical diagnostic tests. And, using the U of S state-of-the- art cyclotron, medical researchers are producing a radioactive tracer, FDG, used for diagnosis and treatment of cancer. Since June of 2016, they have been supplying Royal University Hospital with FDG, enabling 2,000 patients to receive PET/CT scans right close to their Above: Saskatoon Fedoruk Centre Research The SCCS provides companies with access to specialised facilities and expertise to accelerate new nuclear medical technologies homes and families, instead of having to travel to health centres in other provinces. This new capability has created jobs for technicians and highly qualified professionals in Saskatchewan, with more to come. The Saskatchewan Centre for Cyclotron Sciences (SCCS), manufacturer of the FDG isotope, and located in the U of S. It is another world-class scientific facility for innovation in nuclear imaging and treatment in living specimens: plants, animals and humans. It is owned by the University and operated by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. With funding from the Government of Saskatchewan and Western Economic Diversification Canada, the facility is integral to research, training and innovation in nuclear medicine - including radiochemistry, physics and development of new radiopharmaceuticals for medical imaging. The investment enables the SCCS to be a key part of a growing nuclear imaging cluster on campus that includes the Canadian Light Source. The SCCS builds upon the university's pioneering research in nuclear medicine and advances research in the expanding fields of molecular imaging, nuclear medicine and other areas of science that make use of radioisotopes. Since the SCCS was established in 2016, it has provided medical isotopes for nuclear imaging scans of more than 5,000 patients in Saskatchewan (at Royal University Hospital), as well as in Alberta and Manitoba to diagnose and treat cancer. The SCCS also provides companies with access to specialised facilities and expertise to accelerate new nuclear medical technologies towards the marketplace. The city of Saskatoon is also a national leader in community- engaged health research, particularly in using robotic technology – ‘Doctor in a box’ to deliver health care to remote communities, while reducing costs for the provincial health system. New remote tele-robotic health monitoring such as long- distance ultrasound imaging is changing how chronic diseases are diagnosed and treated. One of the pioneers, Dr Ivar Mendez, is providing a service to northern Saskatchewan that saved over CAD$400,000 in one year in the village of Pelican Narrows. Proof that savings can be financial as well as health-related. CONFERENCE & MEETINGS WORLD 17